Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Raynaud Disease | 1 | 2020 | 86 | 0.80 | Why? |
| Ulcer | 1 | 2020 | 128 | 0.77 | Why? |
| Systemic Vasculitis | 1 | 2017 | 74 | 0.63 | Why? |
| Cryoglobulinemia | 1 | 2017 | 144 | 0.59 | Why? |
| Blood Cell Count | 1 | 2021 | 1101 | 0.58 | Why? |
| Metabolomics | 1 | 2021 | 921 | 0.58 | Why? |
| Scleroderma, Systemic | 1 | 2020 | 583 | 0.52 | Why? |
| Insulin Resistance | 1 | 2018 | 669 | 0.50 | Why? |
| Arthritis, Psoriatic | 1 | 2018 | 625 | 0.48 | Why? |
| Lung Diseases, Interstitial | 1 | 2020 | 1476 | 0.38 | Why? |
| Troponin I | 1 | 2017 | 1298 | 0.37 | Why? |
| Paraneoplastic Syndromes | 2 | 2018 | 28 | 0.35 | Why? |
| Arthritis, Rheumatoid | 2 | 2018 | 2043 | 0.35 | Why? |
| Italy | 16 | 2021 | 38444 | 0.33 | Why? |
| Hospital Mortality | 6 | 2021 | 22087 | 0.32 | Why? |
| Referral and Consultation | 1 | 2020 | 4816 | 0.26 | Why? |
| Noninvasive Ventilation | 1 | 2016 | 2329 | 0.25 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.24 | Why? |
| Intercellular Signaling Peptides and Proteins | 2 | 2017 | 245 | 0.24 | Why? |
| Emergency Service, Hospital | 3 | 2020 | 14232 | 0.22 | Why? |
| Rheumatic Diseases | 1 | 2017 | 2675 | 0.21 | Why? |
| Mediastinal Neoplasms | 1 | 2021 | 57 | 0.20 | Why? |
| Bronchoalveolar Lavage | 2 | 2021 | 603 | 0.20 | Why? |
| Neoplasms, Germ Cell and Embryonal | 1 | 2021 | 106 | 0.20 | Why? |
| Vasculitis, Central Nervous System | 1 | 2020 | 97 | 0.19 | Why? |
| Polymyalgia Rheumatica | 1 | 2018 | 64 | 0.18 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 3832 | 0.18 | Why? |
| Thrombin | 1 | 2021 | 325 | 0.18 | Why? |
| Osteoporosis | 2 | 2017 | 410 | 0.18 | Why? |
| Multivariate Analysis | 2 | 2021 | 5440 | 0.17 | Why? |
| Hyperglycemic Hyperosmolar Nonketotic Coma | 1 | 2018 | 58 | 0.17 | Why? |
| Hypovolemia | 1 | 2018 | 65 | 0.17 | Why? |
| Aged, 80 and over | 12 | 2021 | 88759 | 0.16 | Why? |
| Giant Cell Arteritis | 1 | 2018 | 137 | 0.15 | Why? |
| Esophageal and Gastric Varices | 1 | 2017 | 117 | 0.15 | Why? |
| Metabolome | 1 | 2020 | 624 | 0.15 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.15 | Why? |
| Precancerous Conditions | 1 | 2017 | 108 | 0.15 | Why? |
| Sodium | 1 | 2018 | 309 | 0.15 | Why? |
| Risk Assessment | 4 | 2021 | 25439 | 0.15 | Why? |
| Aged | 18 | 2021 | 215776 | 0.14 | Why? |
| Diuretics | 1 | 2017 | 326 | 0.14 | Why? |
| Respiration Disorders | 1 | 2021 | 526 | 0.14 | Why? |
| Hemostasis | 1 | 2021 | 811 | 0.14 | Why? |
| Retrospective Studies | 10 | 2021 | 105322 | 0.14 | Why? |
| Extracellular Vesicles | 1 | 2021 | 607 | 0.13 | Why? |
| Enoxaparin | 1 | 2021 | 1064 | 0.13 | Why? |
| Genetic Association Studies | 1 | 2017 | 559 | 0.13 | Why? |
| Edema | 1 | 2017 | 333 | 0.13 | Why? |
| Immunity, Herd | 1 | 2021 | 1011 | 0.13 | Why? |
| Liver Diseases | 2 | 2020 | 2698 | 0.13 | Why? |
| Male | 22 | 2021 | 367725 | 0.12 | Why? |
| Adrenal Cortex Hormones | 2 | 2020 | 6537 | 0.12 | Why? |
| Female | 21 | 2021 | 380317 | 0.12 | Why? |
| Fluid Therapy | 1 | 2018 | 628 | 0.12 | Why? |
| Middle Aged | 19 | 2021 | 270681 | 0.12 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 2309 | 0.11 | Why? |
| Hospitalization | 6 | 2021 | 54280 | 0.11 | Why? |
| Telephone | 1 | 2020 | 1705 | 0.11 | Why? |
| Chondrocalcinosis | 1 | 2010 | 13 | 0.11 | Why? |
| Humans | 34 | 2021 | 930598 | 0.10 | Why? |
| Biomarkers | 5 | 2021 | 23361 | 0.10 | Why? |
| Predictive Value of Tests | 3 | 2021 | 9537 | 0.10 | Why? |
| Diphosphonates | 1 | 2010 | 121 | 0.10 | Why? |
| Endothelial Cells | 1 | 2020 | 2048 | 0.10 | Why? |
| Blood Platelets | 1 | 2021 | 1704 | 0.10 | Why? |
| Anticoagulants | 2 | 2021 | 9563 | 0.10 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2021 | 9335 | 0.09 | Why? |
| Cohort Studies | 4 | 2021 | 36005 | 0.09 | Why? |
| Thrombosis | 2 | 2021 | 7504 | 0.09 | Why? |
| Hepacivirus | 1 | 2017 | 1509 | 0.09 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.09 | Why? |
| Thromboembolism | 1 | 2021 | 2101 | 0.09 | Why? |
| Smoking | 1 | 2020 | 3358 | 0.08 | Why? |
| Inflammation | 2 | 2020 | 13255 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.08 | Why? |
| Sex Factors | 2 | 2020 | 11014 | 0.08 | Why? |
| Autoimmune Diseases | 1 | 2020 | 1996 | 0.08 | Why? |
| Case-Control Studies | 3 | 2021 | 17671 | 0.08 | Why? |
| Atrial Fibrillation | 1 | 2021 | 2320 | 0.08 | Why? |
| Respiratory Rate | 2 | 2020 | 691 | 0.08 | Why? |
| Interleukin-1 | 1 | 2010 | 438 | 0.08 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.08 | Why? |
| Length of Stay | 2 | 2020 | 11042 | 0.07 | Why? |
| Risk Factors | 6 | 2021 | 71621 | 0.07 | Why? |
| Antirheumatic Agents | 1 | 2020 | 3023 | 0.07 | Why? |
| Age Factors | 3 | 2021 | 21039 | 0.07 | Why? |
| Stress Disorders, Post-Traumatic | 1 | 2021 | 2963 | 0.07 | Why? |
| Dietary Supplements | 1 | 2017 | 2251 | 0.07 | Why? |
| Triage | 2 | 2020 | 7151 | 0.07 | Why? |
| Intensive Care Units | 3 | 2021 | 29594 | 0.07 | Why? |
| Prognosis | 3 | 2021 | 32490 | 0.06 | Why? |
| Vitamin D Deficiency | 1 | 2017 | 1782 | 0.06 | Why? |
| Hyponatremia | 2 | 2018 | 371 | 0.06 | Why? |
| Survival Analysis | 1 | 2016 | 7592 | 0.06 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.06 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.06 | Why? |
| Emergencies | 1 | 2017 | 4095 | 0.06 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.06 | Why? |
| Phospholipases A2 | 1 | 2020 | 33 | 0.06 | Why? |
| Gluconeogenesis | 1 | 2020 | 41 | 0.06 | Why? |
| Oleic Acid | 1 | 2020 | 43 | 0.06 | Why? |
| Respiration, Artificial | 3 | 2021 | 22116 | 0.05 | Why? |
| Phosphatidylethanolamines | 1 | 2020 | 57 | 0.05 | Why? |
| Vitamin D | 1 | 2017 | 2904 | 0.05 | Why? |
| Citric Acid Cycle | 1 | 2020 | 80 | 0.05 | Why? |
| Phosphatidylcholines | 1 | 2020 | 68 | 0.05 | Why? |
| Arachidonic Acid | 1 | 2020 | 90 | 0.05 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.05 | Why? |
| Medical Futility | 1 | 2021 | 150 | 0.05 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.05 | Why? |
| Hydroxychloroquine | 2 | 2020 | 12447 | 0.05 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.05 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2010 | 2483 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2021 | 7301 | 0.05 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.05 | Why? |
| Telemedicine | 2 | 2020 | 25032 | 0.05 | Why? |
| Osmolar Concentration | 1 | 2018 | 86 | 0.04 | Why? |
| Plasma Volume | 1 | 2017 | 9 | 0.04 | Why? |
| Triglycerides | 1 | 2020 | 478 | 0.04 | Why? |
| Hyperaldosteronism | 1 | 2017 | 17 | 0.04 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.04 | Why? |
| Early Termination of Clinical Trials | 1 | 2021 | 1256 | 0.04 | Why? |
| Ascites | 1 | 2017 | 65 | 0.04 | Why? |
| Tomography, X-Ray Computed | 2 | 2021 | 25144 | 0.04 | Why? |
| Blood Gas Analysis | 1 | 2021 | 893 | 0.04 | Why? |
| Amino Acids | 1 | 2020 | 552 | 0.04 | Why? |
| Water-Electrolyte Balance | 1 | 2017 | 136 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.04 | Why? |
| Hypernatremia | 1 | 2018 | 182 | 0.04 | Why? |
| Health Services Accessibility | 1 | 2020 | 10697 | 0.04 | Why? |
| Clinical Deterioration | 1 | 2020 | 473 | 0.04 | Why? |
| Adult | 4 | 2021 | 244371 | 0.04 | Why? |
| Brain Edema | 1 | 2018 | 224 | 0.04 | Why? |
| Oxygen Consumption | 1 | 2020 | 711 | 0.04 | Why? |
| Oximetry | 1 | 2020 | 658 | 0.04 | Why? |
| Protective Factors | 1 | 2021 | 1720 | 0.03 | Why? |
| Patient Discharge | 2 | 2021 | 5696 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2021 | 11304 | 0.03 | Why? |
| False Negative Reactions | 1 | 2020 | 1785 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2021 | 1755 | 0.03 | Why? |
| Sunlight | 1 | 2017 | 287 | 0.03 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.03 | Why? |
| Signal Transduction | 1 | 2010 | 7207 | 0.03 | Why? |
| Receptors, Interleukin-6 | 1 | 2021 | 1383 | 0.03 | Why? |
| Myalgia | 1 | 2018 | 1015 | 0.03 | Why? |
| Bronchoscopy | 1 | 2020 | 991 | 0.03 | Why? |
| Lung | 1 | 2021 | 31049 | 0.03 | Why? |
| Interleukin-6 | 1 | 2010 | 7522 | 0.03 | Why? |
| Disseminated Intravascular Coagulation | 1 | 2020 | 994 | 0.03 | Why? |
| Patient Readmission | 1 | 2020 | 1543 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 56 | 0.03 | Why? |
| Recurrence | 1 | 2020 | 3675 | 0.03 | Why? |
| U937 Cells | 1 | 2010 | 77 | 0.03 | Why? |
| Glycogen Synthase Kinase 3 | 1 | 2010 | 33 | 0.03 | Why? |
| Glycogen Synthase Kinase 3 beta | 1 | 2010 | 45 | 0.03 | Why? |
| Antigens, Differentiation, B-Lymphocyte | 1 | 2010 | 54 | 0.03 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.02 | Why? |
| Cell Separation | 1 | 2010 | 270 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2020 | 6543 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Phosphatidylinositol 3-Kinases | 1 | 2010 | 347 | 0.02 | Why? |
| Blotting, Western | 1 | 2010 | 863 | 0.02 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 372 | 0.02 | Why? |
| Ultraviolet Rays | 1 | 2017 | 1272 | 0.02 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.02 | Why? |
| Receptors, Immunologic | 1 | 2010 | 555 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Logistic Models | 1 | 2020 | 9089 | 0.02 | Why? |
| Liver Cirrhosis | 1 | 2017 | 1810 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.02 | Why? |
| Fever | 1 | 2021 | 7795 | 0.02 | Why? |
| Magnetic Resonance Imaging | 1 | 2020 | 6551 | 0.02 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.02 | Why? |
| Liver | 1 | 2017 | 4007 | 0.02 | Why? |
| Health Status | 1 | 2017 | 3259 | 0.02 | Why? |
| Disease Progression | 1 | 2021 | 13580 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Flow Cytometry | 1 | 2010 | 2393 | 0.01 | Why? |
| Kidney Failure, Chronic | 1 | 2017 | 3222 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Gene Expression | 1 | 2010 | 3332 | 0.01 | Why? |
| Macrophages | 1 | 2010 | 2784 | 0.01 | Why? |
| Monocytes | 1 | 2010 | 2978 | 0.01 | Why? |
| Acute Disease | 1 | 2010 | 6029 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Heart Failure | 1 | 2017 | 6638 | 0.01 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Animals | 1 | 2017 | 78931 | 0.01 | Why? |
Sainaghi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(193)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(307)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_